Yahoo Finance Cigna (CI) Divests Unit to Chubb to Streamline Business
Cigna Corp. CI will be divesting its life, accident and supplemental benefits businesses to insurer Chubb Limited (CB).
Per the deal, the company’s life, accident and supplemental benefits businesses in seven countries will be sold for $5.75 billion dollars. The transaction is expected to be completed in 2022.
This move is in sync with Cigna’s efforts to focus more on its global health services portfolio.
The deal will sell off Cigna's life, accident and supplemental benefits businesses in Hong Kong, Indonesia, Korea, New Zealand, Taiwan and Thailand as well its interest in a joint venture in Turkey.
Cigna will, however, continue to operate its robust international health businesses in the Middle East, Europe, Hong Kong, Singapore and its joint ventures in Australia, China and India.
Proceeds from the deal will be used primarily for share repurchase.
Cigna is steadily streamlining its business to focus on core growth areas. To this end, it divested its non-health insurance unit Group Life and Disability insurance business to New York Life, America’s largest mutual life insurer. Funds from this sale were used in paying off debt and share buybacks.
Time and again, Cigna has pursued acquisitions or partnered with healthcare systems for bolstering its partner networks and strengthening its U.S. presence. These initiatives provided a boost to the medical membership of the company. This year, the company’s medical customer growth is anticipated to be a minimum of 350,000 customers.
The healthcare provider has a strong cash balance and solid cash-generation abilities in place. These tailwinds enabled it to undertake several growth-related efforts and tactically deploy capital through share buybacks and dividend payments. Cigna has been a regular dividend paying company for a while now. Its dividend yield of 2% is higher than the industry’s figure of 1.2%. The company’s leverage ratio of 40.5% at the second-quarter end was almost in line with the company’s long-term debt-to-capitalization target of around 40%.
Cigna carries a Zacks Rank #3 (Hold), currently. Year to date, the stock has slipped 1.4% against its industry's rise of 13.6%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Image Source: Zacks Investment Research
Some better-ranked stocks in the medical space are UnitedHealth Group Inc. UNH, HCA Healthcare, Inc. HCA and Tenet Healthcare Corporation THC, each presently carrying a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report
Cigna Corporation (CI) : Free Stock Analysis Report
Tenet Healthcare Corporation (THC) : Free Stock Analysis Report
HCA Healthcare, Inc. (HCA) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
